Event Details

Ongoing (at time of document)

Description

ODYSSEY Phase 3 program

Participants (1)

Name Type Mentions
patients person 2 View Entity

Source Documents (1)

HOUSE_OVERSIGHT_025892.jpg

Informational Sheet / Press Release (likely an email attachment) • 2.19 MB
View

This document is an informational sheet or press release regarding the pharmaceutical product PRALUENT (alirocumab) manufactured by Sanofi. It details the ODYSSEY Phase 3 clinical trial program, safety information, and side effects. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, likely related to pharmaceutical lobbying or healthcare inquiries found within the broader dataset.

Related Events

Events with shared participants

ODYSSEY Phase 3 program: A comprehensive clinical trial program for an investigational LDL cholesterol lowering therapy (Praluent), involving 14 global trials and over 23,500 patients.

Date unknown • Global

View

ODYSSEY Phase 3 program: A comprehensive clinical trial program for PRALUENT, including 14 global trials with over 23,500 patients.

Date unknown • Global

View

ODYSSEY Phase 3 program: A large-scale clinical trial program for the investigational LDL cholesterol-lowering therapy, Praluent (alirocumab), involving over 23,500 patients in 14 global trials.

Date unknown • Global

View

The ODYSSEY clinical trial program was conducted for the drug Praluent.

Date unknown • worldwide

View

Projected clinical trials for Parkinson's patients.

2016-01-01 • California (implied)

View

ODYSSEY clinical trial program.

2025-12-01

View

Stroke rehabilitation treatment program using imitation-based therapies.

Date unknown • Unspecified medical/research setting

View

Visit to Norman Geschwind's epilepsy clinic where he demonstrated symptoms of temporal lobe epilepsy (hypergraphia, religious conversion, hyposexuality) in patients to the narrator.

Date unknown • Epilepsy Clinic

View

Outbreak of food poisoning involving more than 100 patients.

2012-05-01 • Upstate New York

View

Event Metadata

Type
Unknown
Location
Global
Significance Score
5/10
Participants
1
Source Documents
1
Extracted
2025-11-20 18:59

Additional Data

Source
HOUSE_OVERSIGHT_025892.jpg
Date String
Ongoing (at time of document)

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein event